Come up with a name for your new list and we'll add to it:
Teva Pharmaceuticals - Paragard raised a round of funding on September 12, 2017. Investors include
The Cooper Companies.
Paragard is a copper-releasing device that is placed in the patient's uterus to prevent pregnancy for up to ten years. The copper in Paragard interferes with sperm movement, egg fertilization, and pos…